Skip to main content
Last Updated
In the Matter of Zeneca Group PLC
FTC Matter/File Number
Docket Number
Enforcement Type
Part 2 Consents

Case Summary

Consent order, resolving antitrust concerns relating to Zeneca's merger with Astra AB requires the divestiture of all assets relating to levobupivacaine, a long-acting local anesthetic. The assets were sold to Chiroscience Group plc, the developer of levobupivacaine.

Case Timeline